Inovio Pharmaceuticals
INO
INO
126 hedge funds and large institutions have $113M invested in Inovio Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $142M → $113M (-$28.4M)
26% less call options, than puts
Call options by funds: $449K | Put options by funds: $610K
Holders
126
Holding in Top 10
–
Calls
$449K
Puts
$610K
Top Buyers
| 1 | +$2.08M | |
| 2 | +$1.4M | |
| 3 | +$686K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$588K |
| 5 |
Squarepoint
New York
|
+$569K |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$1.96M | |
| 3 | -$1.85M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$722K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$674K |